Brandie Strange
Psychiatric/Mental Health · Oklahoma City, OKNPI 1699102616
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,242 and has fallen 73.8% since, to $325 in 2025.
Across 277 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$563
- AbbVie$507
- Neurocrine Biosciences, Inc.$503
- Teva Pharmaceuticals USA, Inc.$456
- Otsuka America Pharmaceutical, Inc.$397
- Johnson & Johnson$374
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,976100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 33 | $563 |
| AbbVie | 43 | $507 |
| Neurocrine Biosciences, Inc. | 33 | $503 |
| Teva Pharmaceuticals USA, Inc. | 37 | $456 |
| Otsuka America Pharmaceutical, Inc. | 20 | $397 |
| Johnson & Johnson | 31 | $374 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $326 |
| Vanda Pharmaceuticals Inc. | 16 | $290 |
| Sunovion Pharmaceuticals Inc. | 23 | $225 |
| Indivior Inc. | 8 | $117 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Lundbeck LLC | 2 | $34 |
| Sage Therapeutics, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
How this compares
$3,976 in reported general payments places this provider in the 75th percentile of 231 psychiatric/mental health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 27 | $220,493 |
| VraylarCariprazine Hcl | 98 | $150,289 |
| RexultiBrexpiprazole | 24 | $34,803 |
| Risperdal ConstaRisperidone Microspheres | 12 | $30,475 |
| Aripiprazole | 57 | $10,810 |
| BelsomraSuvorexant | 18 | $7,095 |
| Duloxetine Hcl | 92 | $3,750 |
| Lamotrigine | 108 | $2,479 |
| Bupropion XlBupropion Hcl | 83 | $2,432 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 74 | $2,388 |
| Trazodone Hcl | 95 | $2,069 |
| Quetiapine Fumarate | 76 | $1,709 |
| Clonazepam | 209 | $1,610 |
| Olanzapine OdtOlanzapine | 13 | $1,503 |
| Mirtazapine | 62 | $1,454 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $503 | $220,49327 claims |
| AbbVieVraylar | $507 | $150,28998 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $397 | $34,80324 claims |
| Johnson & JohnsonRisperdal Consta | $374 | $30,47512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 231 psychiatric/mental health providers in Oklahoma.
Other psychiatric/mental health in Oklahoma City
- Sylvie MawohOklahoma City$14K
- Imelda GarnerOklahoma City$9K
- Kathryn SheltonOklahoma City$8K
- Nicole BrownOklahoma City$8K
- Ragina HolimanOklahoma City$7K
- Tierra PageOklahoma City$7K
- Kelsey WilsonOklahoma City$6K
- Jamie HolzOklahoma City$6K
- Robin Potter-KimballOklahoma City$6K
- Sue RollinsOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.